Related Experiment Video
Updated: Jun 6, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Stable versus progressive hepatitis unique to pregnancy
Vivian Schutt1, Julia Uhanova, Carol Schneider
1Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Mothers with hepatitis unique to pregnancy (HUP) and normal liver function tests can safely deliver at term. Standard liver function tests may help guide delivery timing for HUP patients.
Area of Science:
- Obstetrics and Gynecology
- Hepatology
- Neonatology
Background:
- Hepatitis unique to pregnancy (HUP) often necessitates urgent fetal delivery in the second or third trimester.
- The decision for early delivery in HUP is typically based on clinical urgency.
Purpose of the Study:
- To evaluate if standard liver function tests (serum bilirubin, international normalized ratio) can identify mothers with HUP and their neonates who would benefit from early delivery.
- To assess the impact of delivery timing on maternal and neonatal outcomes in HUP.
Main Methods:
- Retrospective analysis of 149 patients with HUP, classified into normal (stable-HUP, n=118) and abnormal (progressive-HUP, n=31) liver function test groups.
- Outcomes measured included maternal hospital stay post-delivery and neonatal Apgar scores at 0 and 5 minutes.
Main Results:
- Maternal hospital stay was similar for stable-HUP patients delivered early versus at term.
- Neonatal Apgar scores at birth were comparable between early and term delivery in stable-HUP, but significantly higher at 5 minutes for term deliveries.
- Insufficient data for term deliveries in the progressive-HUP group precluded similar comparisons.
Conclusions:
- Mothers with HUP and normal liver function tests can be managed expectantly until term without adverse effects on maternal or neonatal health.
- Further research is needed to establish whether abnormal liver function tests in HUP warrant immediate fetal delivery.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
10:25"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test